Roche Venture Fund
Roche Venture Fund is the corporate venture capital arm of F. Hoffmann-La Roche Ltd, managing a CHF 750M evergreen fund that invests in early to mid-stage life science companies across pharmaceuticals, diagnostics, and digital health, with operations in Basel and South San Francisco.
- Company typePrivate
- Founded2002
- HeadquartersBasel, Switzerland
- Headcount5,001–10,000
- GTM typeB2B
- OfferingServices
What Roche Venture Fund does
Roche Venture Fund is the corporate venture capital arm of F. Hoffmann-La Roche Ltd, a global pharmaceutical and diagnostics company headquartered in Basel, Switzerland. Established in 2002, the fund manages a CHF 750 million (approximately $940 million) evergreen capital base and invests in early to mid-stage life science companies across three core verticals: pharmaceuticals, diagnostics, and digital health. The fund's stated mission is to develop commercially successful innovative life science companies through financial investment, active portfolio involvement, and provision of strategic guidance beyond capital deployment.
The fund operates from two locations, Basel (Roche headquarters) and South San Francisco (a major US biotech hub), enabling transatlantic deal sourcing and portfolio company support. Its current portfolio comprises more than 30 companies, with the fund employing an evergreen structure that eliminates traditional fixed-fund-life constraints and allows sustained, long-term capital availability for life science development timelines. The fund focuses on generating financial returns while offering portfolio companies access to Roche's broader resources, industry expertise, and strategic partnership opportunities.
Anja Harmeier was appointed head of Roche Venture Fund in January 2025, succeeding Carole Nuechterlein who retired. Harmeier brings prior Roche Venture Fund tenure (2016-2020) and operating experience as CEO of biotech company Rewind Therapeutics. The fund does not disclose revenue, AUM-based management fees, or realized returns as a standalone entity; financial performance is reported at the parent company level. Recent activity includes co-leading a $50 million Series B financing round for COUR Pharma in June 2026, with syndication across multiple CVC partners including Lumira Ventures, Pfizer Ventures, Sanofi, and specialized funds such as T1D Fund.
Roche Venture Fund firmographics
Firmographics- Name
- Roche Venture Fund
- Legal name
- F. Hoffmann-La Roche Ltd
- Website
- https://venturefund.roche.com
- Company type
- Private
- Founded year
- 2002
- Operating status
- Operating
- Headcount range
- 5,001–10,000 employees
- Short description
- Roche Venture Fund is the corporate venture capital arm of F. Hoffmann-La Roche Ltd, managing a CHF 750M evergreen fund that invests in early to mid-stage life science companies across pharmaceuticals, diagnostics, and digital health, with operations in Basel and South San Francisco.
- Ownership category
- akta.pro rank
Roche Venture Fund industry classification
Industry- Product category
- Corporate Venture Capital
- NAICS
- Portfolio Management and Investment Advice (523940), Other Investment Pools and Funds (5259)
- SIC
- Investment Advice (6282)
- akta.pro primary industry
- Early-Stage Venture Capital (Series A/B) (FSANAAAB)
Keywords
Where Roche Venture Fund is headquartered
LocationHeadquarters
- HQ city
- Basel
- HQ country
- Switzerland
- HQ region
- Europe
Offices2 records
Markets served
Roche Venture Fund business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations
Distribution channels1 record
Marketing channels2 records
Roche Venture Fund product offering
Product offeringCore offering
Roche Venture Fund is the corporate venture capital arm of F. Hoffmann-La Roche Ltd, operating a CHF 750 million evergreen fund that invests in life science companies across pharmaceuticals, diagnostics, and digital health. The fund deploys equity capital into early- to mid-stage startups while providing strategic guidance, industry expertise, and active portfolio involvement aimed at generating financial returns and fostering innovation.
Product overview
Roche Venture Fund operates as a single unified investment vehicle — a CHF 750 million evergreen fund that deploys capital into life science startups in pharmaceuticals, diagnostics, and digital health. The fund provides not only capital but also strategic expertise and long-term vision to portfolio companies, aiming to develop commercially successful innovative life science companies.
Differentiator
Problem solved
Functional benefit
Products and services
- Roche Venture Fund CHF 750 million evergreen corporate venture capital fund that invests in life science companies across pharmaceuticals, diagnostics, and digital health, with focus on financial returns and active portfolio involvement.
Companies that use Roche Venture Fund
Customer profileSegments1 record
Ideal customer profiles1 record
Roche Venture Fund technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Roche Venture Fund partnerships and signals
Strategic signalScale indicators2 records
Recent moves3 records
Expansion highlights4 records
Roche Venture Fund competitors and assessment
Company assessmentMarket position
Competitive moat4 records
Key highlights5 records
Customer concentration
Roche Venture Fund social profiles
Digital presenceRoche Venture Fund financial estimates
Financial estimateRevenue estimate
Valuation estimate
Roche Venture Fund leadership team
Management profileNumber of profiles
Profiles1 record
Roche Venture Fund funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Roche Venture Fund M&A and investment
M&A and investmentM&A
Investments132 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Roche Venture Fund
What does Roche Venture Fund do?
Roche Venture Fund is the corporate venture capital arm of F. Hoffmann-La Roche Ltd, operating a CHF 750 million evergreen fund that invests in life science companies across pharmaceuticals, diagnostics, and digital health. The fund deploys equity capital into early- to mid-stage startups while providing strategic guidance, industry expertise, and active portfolio involvement aimed at generating financial returns and fostering innovation.
Is Roche Venture Fund a public or private company?
Roche Venture Fund is a private company. It is classified as corporate owned and is currently operating.
When was Roche Venture Fund founded?
Roche Venture Fund was founded in 2002. It employs 5,001 to 10,000 people.
Where is Roche Venture Fund based?
Roche Venture Fund is headquartered in Basel, Switzerland, in the Europe region.
Does Roche Venture Fund have an API?
No public API is recorded for Roche Venture Fund.
What industry is Roche Venture Fund in?
Roche Venture Fund's product category is Corporate Venture Capital. Its primary akta.pro industry code is FSANAAAB, Early-Stage Venture Capital (Series A/B). Its NAICS code is 523940 and its SIC code is 6282.